Table 1. Baseline characteristics of patients.
| Characteristics | Value | |
|---|---|---|
| Total | 6,275 | |
| Men (No.) | 3,966 (63.2) | |
| Age (years) | 67.4±10.8 | |
| BMI (kg/m2) | 24.6±3.3 | |
| Type of AF | ||
| Paroxysmal | 4,100 (65.3) | |
| Persistent | 1,883 (30) | |
| Permanent | 182 (2.9) | |
| Unknown | 110 (1.7) | |
| CHA2DS2-VASc score | 2.7±1.7 | |
| HAS-BLED score | 1.9±1.1 | |
| Valve disease | 643 (10.3) | |
| HF | 632 (10.1) | |
| Hypertension | 4,240 (67.6) | |
| Diabetes mellitus | 1,597 (25.5) | |
| History of stroke/TIA | 952 (15.2) | |
| History of MI/PAD | 533 (8.5) | |
| Cancer | 630 (10) | |
| CKD | 621 (9.9) | |
| ESRD | 101 (1.6) | |
| History of bleeding | 582 (9.3) | |
| Treatment | ||
| NOAC or warfarin | 4,399 (70.1) | |
| Rate control | 3,383 (53.9) | |
| Rhythm control | 3,414 (54.4) | |
Data are presented as mean±standard deviation or number (percentage).
AF = atrial fibrillation; BMI = body mass index; CKD = chronic kidney disease; ESRD = end-stage renal disease; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, concomitant drugs/alcohol; HF = heart failure; MI = myocardial infarction; NOAC = non-vitamin K antagonist oral anticoagulation; PAD = peripheral artery disease; TIA = transient ischemic attack.